Apollon Wealth Management LLC Has $1.06 Million Stake in Axon Enterprise, Inc (NASDAQ:AXON)

Apollon Wealth Management LLC increased its position in Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 63.0% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 2,018 shares of the biotechnology company's stock after buying an additional 780 shares during the quarter. Apollon Wealth Management LLC's holdings in Axon Enterprise were worth $1,061,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors and hedge funds also recently made changes to their positions in AXON. Pinion Investment Advisors LLC lifted its holdings in shares of Axon Enterprise by 3.0% in the 1st quarter. Pinion Investment Advisors LLC now owns 649 shares of the biotechnology company's stock worth $341,000 after purchasing an additional 19 shares in the last quarter. Kentucky Retirement Systems increased its holdings in Axon Enterprise by 0.4% in the 1st quarter. Kentucky Retirement Systems now owns 4,953 shares of the biotechnology company's stock worth $2,605,000 after acquiring an additional 19 shares during the last quarter. WCM Investment Management LLC boosted its stake in Axon Enterprise by 0.8% in the 1st quarter. WCM Investment Management LLC now owns 2,441 shares of the biotechnology company's stock worth $1,306,000 after purchasing an additional 19 shares during the period. HBK Sorce Advisory LLC boosted its position in shares of Axon Enterprise by 4.6% during the 1st quarter. HBK Sorce Advisory LLC now owns 451 shares of the biotechnology company's stock valued at $237,000 after acquiring an additional 20 shares during the last quarter. Finally, Prudent Man Advisors LLC boosted its position in shares of Axon Enterprise by 1.6% during the 1st quarter. Prudent Man Advisors LLC now owns 1,298 shares of the biotechnology company's stock valued at $683,000 after acquiring an additional 20 shares during the last quarter. Institutional investors and hedge funds own 79.08% of the company's stock.

Axon Enterprise Price Performance

Shares of NASDAQ AXON opened at $745.86 on Friday. The company has a fifty day moving average price of $762.11 and a 200 day moving average price of $644.50. The company has a current ratio of 2.83, a quick ratio of 2.62 and a debt-to-equity ratio of 0.68. Axon Enterprise, Inc has a 1-year low of $279.02 and a 1-year high of $830.21. The firm has a market cap of $58.07 billion, a PE ratio of 180.16, a PEG ratio of 85.50 and a beta of 1.29.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, beating the consensus estimate of $1.34 by $0.07. Axon Enterprise had a net margin of 14.86% and a return on equity of 5.81%. The firm had revenue of $603.63 million for the quarter, compared to analysts' expectations of $585.67 million. During the same period in the prior year, the firm earned $1.15 EPS. The business's revenue was up 31.3% on a year-over-year basis. Research analysts predict that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Analyst Ratings Changes

A number of equities research analysts have recently commented on AXON shares. Bank of America increased their target price on Axon Enterprise from $750.00 to $895.00 and gave the stock a "buy" rating in a research note on Wednesday, June 4th. UBS Group began coverage on Axon Enterprise in a research note on Wednesday. They issued a "neutral" rating and a $820.00 price objective for the company. JPMorgan Chase & Co. raised their price target on Axon Enterprise from $730.00 to $850.00 and gave the stock an "overweight" rating in a research note on Thursday. The Goldman Sachs Group lifted their price target on Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a report on Wednesday, May 14th. Finally, Wolfe Research started coverage on Axon Enterprise in a research report on Monday, July 7th. They set an "outperform" rating for the company. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and eleven have given a buy rating to the company's stock. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and a consensus target price of $763.75.

Insider Activity

In other news, Director Michael Garnreiter sold 5,913 shares of Axon Enterprise stock in a transaction dated Wednesday, June 4th. The shares were sold at an average price of $760.00, for a total transaction of $4,493,880.00. Following the completion of the transaction, the director directly owned 17,740 shares in the company, valued at $13,482,400. This trade represents a 25.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Brittany Bagley sold 3,400 shares of Axon Enterprise stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $700.00, for a total transaction of $2,380,000.00. Following the completion of the sale, the chief financial officer directly owned 131,833 shares in the company, valued at approximately $92,283,100. This represents a 2.51% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 44,642 shares of company stock valued at $30,500,428. 4.40% of the stock is currently owned by company insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.